- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Proposed standard for CAC CT screening reduces dose and improves diagnosis
A new standard proposed by a consortium of researchers and manufacturers at the RSNA meeting would make coronary artery calcium (CAC) screening with CT safer and more useful in assessing early heart disease.
A new standard proposed by a consortium of researchers and manufacturers at the RSNA meeting would make coronary artery calcium (CAC) screening with CT safer and more useful in assessing early heart disease.
The proposed standards would ensure that all manufacturers play by the same rules, said Cynthia McCollough, Ph.D., an associate professor of radiologic physics at the Mayo Clinic in Rochester, MN.
"The problem has been in the variability of the scoring in CAC screening," she said. "There are a variety of CT scanners using different scoring systems to produce CAC screening results. In order for these numbers to be meaningful and comparable, we need to be measuring and scoring in the same way."
The consortium developed a calcium calibration phantom for testing CAC screening on all major manufacturers' CT scanners. In addition, the group set standards for body size that will help reduce the radiation dose to small and medium-sized patients.
The new standard uses a physically based score to evaluate calcification, which will allow portability of screening between machines. Instead of using a CT number, it measures the actual density of calcium in the artery. Any amount greater than 100 mg/cc is considered significant.
McCollough cautioned that the new standard has some drawbacks; for example, it becomes less accurate as more motion is introduced into the study.
The consortium included researchers from the Mayo Clinic, the Cleveland Clinic, and the Institute for Medical Physics in Erlangen, Germany, as well as participants from the medical divisions of GE, Philips, Siemens, and Toshiba.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the recent RSNA conference.
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.
